Comparison Gain Therapeutics (GANX) with Competitors
Gain Therapeutics (GANX) industry is Biotechnology.
Debt-to-Equity
GANX2.67%
Industry28.27%
Upside-90.57%
Free Cash Flow Yield
GANX-27.14%
Industry-1.75%
Upside-25.39%
P/E
GANX-2.92
Industry-20.52
Upside+1759.82%
P/S
GANX255.50
Industry10.01
Upside+2451.55%
P/B
GANX5.13
Industry5.15
Upside-0.33%